GN 2016 Family Trust u/a/d August 12, 2016
SEC CIK 1757453 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORGO | Organogenesis Holdings Inc. | 10% | 51.09M | $248.2K | $51.7K | 3 | 2021-11-18 | 2024-11-27 |
Most active insiders at ORGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NUSSDORF GLENN H | Dir, 10% | — | $2.62M |
| 2 | Driscoll Michael Joseph | Dir | $26.7K | — |
| 3 | Leibowitz Arthur S | Dir | $13.4K | — |
| 4 | Lustig Garrett | Dir | — | — |
| 5 | Cavorsi Robert | VP, Strategy | — | — |
| 6 | Quintero Gilberto | Dir | — | — |
| 7 | Francisco David | CFO | — | — |
| 8 | Duraibabu Prathyusha | Dir | — | — |
| 9 | Korfin Michele Ilene | Dir | — | — |
| 10 | Montecalvo Antonio S. | VP, Health Policy | — | — |
GN 2016 Family Trust u/a/d August 12, 2016 made no open-market trades at ORGO in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-02 | 2024-11-27 | ORGO | Organogenesis Holdings Inc. | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | D - Sale to Iss | $4.06 | -500.0K | 51.09M | -1.0% | -$2.03M | |
| 2023-04-14 | 2023-04-12 | ORGO | Organogenesis Holdings Inc. | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | S - Sale | $2.07 | -25.0K | 59.22M | -0.0% | -$51.7K | |
| 2021-11-22 | 2021-11-18 | ORGO | Organogenesis Holdings Inc. | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | P - Purchase | $9.93 | +25.0K | 59.45M | +0.0% | +$248.2K |
Purchase Sale Sale after option exercise All abbreviations